Interaction and Assembly of HBV Structural Proteins: Novel Target Sites of Anti-HBV Agents

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|7|3|251-256

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.7, Iss.3, 2007-09, pp. : 251-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nucleoside Analogs as Anti-HBV Agents

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-05 ,pp. : 851-865

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance

By  

Current Medicinal Chemistry, Vol. 22, Iss. 34, 2015-11 ,pp. : 3922-11

Bentham Science Publishers

Access to resources Recommend Favorite

Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses

By Hann Hie-Won  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2243-2249

Informa Healthcare

Access to resources Recommend Favorite

HBV vaccine: school children preferred target in Switzerland

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 275, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Anti-TNFα drugs linked to HBV reactivation

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite